What Have We Done, What Are We Doing?
The Cannonball Kids' cancer Foundation was founded June 10, 2014, by Cannon Wiggins' parents, Michael and Melissa Wiggins. In it's first year, through hard work, dedication and worldwide support, the foundation achieved $100K in donations, which was successfully put towards funding a pediatric brain cancer clinical trial at the GRU Cancer Center in Augusta, Georgia. Click here to read about the trial and its potential impact on pediatric cancer.
The Cannonball Kids' cancer Foundation team and supporters show no sign of slowing down. Entering its second year, the foundation has released a new book, "Thankful for the Fight", an inspiring story about Cannon's journey and his family's fight to save his life. All proceeds from the sale of the book will go towards funding a new pediatric cancer research project. Click here for more information or to purchase the book. Look for book signing events around the U.S. starting fall 2015 (check Events page for further details once available). If you are interested in promoting the book via media outlets or would like to request interviews/appearances, please contact Debra Brett at email@example.com.
In addition, the Cannonball Kids' cancer Card Club continues to generate smiles and donations worldwide. At last count, CKc Card Club events have been hosted in 40 states across the U.S.A. and nine countries worldwide. Thousands of dollars have been raised for pediatric cancer research! However, most importantly, smiles and inspiration have been delivered to children fighting for their lives in hospitals, both domestically and internationally. Learn how you can host a Card Club event in your community.
Of course, securing donations to fund pediatric cancer research projects remains our priority. Make a donation today. Thank you for helping us Cannonball Kids' cancer!
Follow us on Facebook. www.facebook.com/Cannonballingcancer
Cannonball Kids' cancer Foundation is dedicated to finding cures for all childhood cancers by funding critical research needed to improve antiquated treatments and eliminate the occurrence of life-threatening side effects and secondary cancers.